Additionally, his leadership of large teams of physicians and scientists (at both Johns Hopkins and Thomas Jefferson) dedicated to a better understanding of pancreatic neoplasia, has generated a plethora of new knowledge relevant to the early detection, screening, categorization, and therapy of pancreatic and related types of cancer.